​

Oaktree Acquisition Corp. III Life Sciences Stock (NASDAQ:OACC)

OwnershipFinancialsChart

Previous Close

$10.60

52W Range

$9.95 - $10.85

50D Avg

$10.57

200D Avg

$10.40

Market Cap

$259.99M

Avg Vol (3M)

$55.70K

Beta

-0.13

Div Yield

-

OACC Company Profile

Oaktree Acquisition Corp. III Life Sciences focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to acquire companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was incorporated in 2024 and is based in Los Angeles, California.

Show More

Industry

Shell Companies

Sector

Financial Services

Exchange

NASDAQ

ADR

-

Country

US

Employees

3

IPO Date

Dec 16, 2024

Website

OACC Performance

OACC Financial Summary

Dec 24
Revenue-
Operating Income$-703.61
Net Income$2.66K
EBITDA-
Basic EPS-
Diluted EPS-

Fiscal year ends in Dec 24 | Currency in USD

Peer Comparison

TickerCompany
COPLCopley Acquisition Corp
AACBArtius II Acquisition Inc. Class A Ordinary Shares
MLACMountain Lake Acquisition Corp.
RACRithm Acquisition Corp.
SOULSoulpower Acquisition Corp.
PMTRPerimeter Acquisition Corp. I Class A Ordinary Shares
FACTFACT II Acquisition Corp
CGCTCartesian Growth Corporation III
MBAVM3-Brigade Acquisition V Corp. Class A Ordinary shares